Picture of Genetron Holdings logo

GTH Genetron Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Genetron Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-465-676-3,069-503-811
Depreciation
Amortisation
Non-Cash Items2573842,84067199
Unusual Items
Other Non-Cash Items
Changes in Working Capital-20.662.8-125-15273.9
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-201-197-301-524-460
Capital Expenditures-47.4-25.6-50-85.9-82.1
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items219-71.2-34.6-50.4-5.69
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities171-96.8-84.6-136-87.8
Financing Cash Flow Items-10.6-10.3-23.4-16.8-26.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities49.43721,745-58.471.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash20.177.81,236-737-463